Study of Multimodal Evoked Potentials in Patients With Type 1 Gaucher's Disease

Abstract

To detect early subclinical nervous dysfunction in Gaucher's disease type 1, we carried out motor, brainstem auditory, visual, and somatosensory evoked potentials in 17 patients with Gaucher's disease type 1. Central motor evoked potential abnormalities were found in nine patients (69.2%), consisting of an increased motor threshold in all, with prolonged central motor conduction time in two patients. Brainstem auditory evoked potentials were abnormal in five patients (31.2%), and the most frequent abnormality was a bilateral increased I—III interpeak latency. Visual evoked potentials showed a delayed latency of the P100 wave in four patients (25%). Somatosensory evoked potential abnormalities were found in three patients (18.7%), consisting of an increased N13—N20 interval in two patients and a not reproducible N13 wave in one patient. Our findings suggest that the multimodal evoked potential approach provides information about nervous subclinical damage in Gaucher's disease type 1; transcranial magnetic stimulation proved to be the most sensitive tool. Early detection of subclinical neurologic dysfunction can be useful in view of more effective therapeutic strategies. (J Child Neurol 2005;20:124—128).

Get full access to this article

View all access options for this article.

References

Beutler E. , Kuhl W. , Sorge J. : Glucocerebrosidase `processing' and gene expression in various forms of Gaucher disease. Am J Hum Genet 1985;37:1062—1070.

Beutler E. : Gaucher disease: New molecular approaches to diagnosis and treatment. Science 1992;256:794—799.

Dahl N. , Lagerstrom M. , Erikson A. , Pettersson U. : Gaucher disease type III (norrbottnian type) is caused by a single mutation in exon 10 of the glucocerebrosidase gene. Am J Hum Genet 1990;47:275—278.

Neil JF , Glew RH , Peters SP : Familial psychosis and diverse neurologic abnormalities in adult-onset Gaucher's disease. Arch Neurol 1979;36:95—99.

Neudorfer O. , Giladi N. , Elstein D. , et al: Occurrence of Parkinson's syndrome in type I Gaucher disease. QJM 1996;89:691—694.

Barton NW , Furbish FS , Murray GJ , et al: Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease. Proc Natl Acad Sci U S A 1990;87:1913—1916.

Schiffmann R. , Heyes MP , Aerts JM , et al: Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease. Ann Neurol 1997;42:613—621.

Aoki M. , Takahashi Y. , Miwa Y. , et al: Improvement of neurological symptons by enzyme replacement therapy for Gaucher disease type IIIb. Eur J Pediatr 2001;160:63—64.

Vellodi A. , Bembi B. , de Villemeur TB , et al: Management of neuronopathic Gaucher disease: A European consensus . J Inherit Metab Dis 2001;24:319—327.

10.

Harris CM , Taylor DS , Vellodi A. : Ocular motor abnormalities in Gaucher disease. Neuropediatrics 1999;30:289—293.

11.

Perretti A. , Petrillo A. , Pelosi L. , et al: Detection of early abnormalities in mucopolysaccharidoses by the use of visual and brainstem auditory evoked potentials. Neuropediatrics 1990;21:83—86.

12.

Toscano E. , Perretti A. , Balbi P. , et al: Detection of subclinical central nervous system abnormalities in two patients with mucolipidosis III by the use of motor and somatosensory evoked potentials . Neuropediatrics 1998;29:40—42.

13.

Kaga M. , Azuma CH , Imamura T. , et al: Auditory brainstem response (ABR) in infantile Gaucher's disease. Neuropediatrics 1982;13: 207—210.

14.

Lacey DJ , Terplan K. : Correlating auditory evoked and brainstem histologic abnormalities in infantile Gaucher's disease. Neurology 1984;34:539—541.

15.

Bamiou DE , Campbell P. , Liasis A. , et al: Audiometric abnormalities in children with Gaucher disease type 3. Neuropediatrics 2001;32:136—141.

16.

Tuzun E. , Baykan B. , Gurses C. , Gokyigit A. : Longterm follow-up of electroencephalographic and clinical findings of a case with Gaucher's disease type 3a. Seizure 2000 ;9:469—472.

17.

Garvey MA , Toro C. , Goldstein S. , et al: Somatosensory evoked potentials as a marker of disease burden in type 3 Gaucher disease. Neurology 2001;56:391—394.

18.

Parenti G. , Filocamo M. , Titomanlio L. , et al: A novel mutation of the β-glucocerebrosidase gene associated with neurologic manifestations in three sibs. Clin Genet 1998;53:281—285.

19.

Patton HD , Amassian VE : Single and multiple unit analysis of cortical stage of pyramidal tract activation . J Neurophysiol 1954;17:354—363.

20.

Muller K. , Homberg V. , Lenard HG : Magnetic stimulation of motor cortex and nerve roots in children. Maturation of cortico-motoneuronal projections. Electroencephalogr Clin Neurophysiol 1991;81:63—70.

21.

Caramia MD , Desiato MT , Cicinelli P. , et al: Latency jump of “relaxed” versus “contracted” motor evoked potentials as a marker of cortico-spinal maturation. Electroencephalogr Clin Neurophysiol 1993;89:61—66.

22.

Eyre J.A. , Miller S. , Ramesh V. : Constancy of central conduction delays during development in man: Investigation of motor and somatosensory pathways. J Physiol 1991;434:441—452.

23.

Chiappa KH : Evoked Potentials in Clinical Medicine, 2nd ed. New York, KH Chiappa, 1990.

24.

Lwin A. , Orvisky E. , Goker-Alpan O. , et al: Glucocerebrosidase mutations in subjects with parkinsonism. Mol Genet Metab 2004; 81:70—73.